Slc25a37 Mouse (-)-demecolcine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Demecolcine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 Slc25a37 Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Mouse 1,2-dimethylhydrazine affects expression EXP 6480464 1 and 2-Dimethylhydrazine affects the expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Mouse 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Mouse 17beta-estradiol multiple interactions ISO Slc25a37 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Mouse 17beta-estradiol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC25A37 mRNA CTD PMID:30165855 Slc25a37 Mouse 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC25A37 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC25A37 mRNA CTD PMID:29581250 Slc25a37 Mouse 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants results in increased abundance of 2 more ... CTD PMID:38995820 Slc25a37 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 and PMID:29673856 Slc25a37 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A37 mRNA CTD PMID:28213091 Slc25a37 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A37 mRNA CTD PMID:21570461 Slc25a37 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:21215274 Slc25a37 Mouse 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of SLC25A37 mRNA CTD PMID:19812364 Slc25a37 Mouse 2-palmitoylglycerol increases expression ISO SLC25A37 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC25A37 mRNA CTD PMID:37199045 Slc25a37 Mouse 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:25172293 Slc25a37 Mouse 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC25A37 mRNA CTD PMID:20188158 Slc25a37 Mouse 6-propyl-2-thiouracil decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC25A37 mRNA CTD PMID:24780913 Slc25a37 Mouse acrolein multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 Slc25a37 Mouse aflatoxin B1 increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC25A37 gene and Aflatoxin B1 results in increased methylation of SLC25A37 intron CTD PMID:28458013 and PMID:30157460 Slc25a37 Mouse Aflatoxin B2 alpha increases methylation ISO SLC25A37 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Mouse all-trans-retinoic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC25A37 mRNA CTD PMID:17218384 Slc25a37 Mouse alpha-pinene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 Slc25a37 Mouse anthracen-2-amine increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 2-anthramine results in increased expression of SLC25A37 mRNA CTD PMID:23038007 Slc25a37 Mouse aristolochic acid A decreases expression ISO SLC25A37 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC25A37 mRNA CTD PMID:33212167 Slc25a37 Mouse arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 Slc25a37 Mouse arsenous acid multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Mouse atrazine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Atrazine results in increased expression of SLC25A37 mRNA CTD PMID:22378314 Slc25a37 Mouse avobenzone increases expression ISO SLC25A37 (Homo sapiens) 6480464 avobenzone results in increased expression of SLC25A37 mRNA CTD PMID:31016361 Slc25a37 Mouse benzo[a]pyrene decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A37 mRNA CTD PMID:26238291 and PMID:30453624 Slc25a37 Mouse benzo[a]pyrene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 Slc25a37 Mouse benzo[a]pyrene affects methylation ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC25A37 promoter CTD PMID:27901495 Slc25a37 Mouse benzo[a]pyrene diol epoxide I decreases expression ISO SLC25A37 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Slc25a37 Mouse benzo[e]pyrene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Mouse bisphenol A multiple interactions ISO Slc25a37 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC25A37 mRNA CTD PMID:32156529 Slc25a37 Mouse bisphenol A increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:32145629 Slc25a37 Mouse bisphenol A affects expression ISO Slc25a37 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SLC25A37 mRNA CTD PMID:25181051 Slc25a37 Mouse caffeine decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Caffeine results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Slc25a37 Mouse cobalt dichloride increases expression ISO SLC25A37 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:19376846 Slc25a37 Mouse cobalt dichloride increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:24386269 Slc25a37 Mouse cocaine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cocaine results in increased expression of SLC25A37 mRNA CTD PMID:15009677 and PMID:16710320 Slc25a37 Mouse copper atom multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Mouse copper(0) multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Mouse copper(II) sulfate increases expression ISO SLC25A37 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SLC25A37 mRNA CTD PMID:19549813 Slc25a37 Mouse coumarin increases phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of SLC25A37 protein CTD PMID:35688186 Slc25a37 Mouse coumestrol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Coumestrol results in decreased expression of SLC25A37 mRNA CTD PMID:19167446 Slc25a37 Mouse crocidolite asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of SLC25A37 mRNA CTD PMID:24160326 Slc25a37 Mouse crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29279043 Slc25a37 Mouse crocidolite asbestos decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29523930 Slc25a37 Mouse cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 Slc25a37 Mouse cyclosporin A increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC25A37 mRNA CTD PMID:25562108 Slc25a37 Mouse cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 Slc25a37 Mouse diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 Slc25a37 Mouse diarsenic trioxide multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Mouse dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 Slc25a37 Mouse Dibutyl phosphate affects expression ISO SLC25A37 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC25A37 mRNA CTD PMID:37042841 Slc25a37 Mouse dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC25A37 mRNA CTD PMID:21266533 Slc25a37 Mouse disulfiram multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Mouse dorsomorphin multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Mouse elemental selenium increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 Slc25a37 Mouse endosulfan increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SLC25A37 mRNA CTD PMID:29391264 Slc25a37 Mouse entinostat multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Mouse entinostat decreases expression ISO SLC25A37 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC25A37 mRNA CTD PMID:26272509 Slc25a37 Mouse epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 Slc25a37 Mouse epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of SLC25A37 mRNA CTD PMID:35436446 Slc25a37 Mouse ethanol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 Slc25a37 Mouse ethyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Mouse fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA CTD PMID:28329830 Slc25a37 Mouse flutamide increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Flutamide results in increased expression of SLC25A37 mRNA CTD PMID:24136188 Slc25a37 Mouse folic acid increases expression EXP 6480464 Folic Acid results in increased expression of SLC25A37 mRNA CTD PMID:25629700 Slc25a37 Mouse folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Mouse FR900359 affects phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLC25A37 protein CTD PMID:37730182 Slc25a37 Mouse gentamycin increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of SLC25A37 mRNA CTD PMID:33387578 Slc25a37 Mouse heroin increases expression ISO SLC25A37 (Homo sapiens) 6480464 Heroin results in increased expression of SLC25A37 mRNA CTD PMID:16710320 Slc25a37 Mouse inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 Slc25a37 Mouse manganese(II) chloride increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of SLC25A37 mRNA CTD PMID:28801915 Slc25a37 Mouse metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Mouse methapyrilene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Mouse methoxyacetic acid decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 methoxyacetic acid results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Mouse methyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Mouse methylmercury chloride decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 methylmercuric chloride results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Mouse Monobutylphthalate decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 monobutyl phthalate results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Mouse N-methyl-4-phenylpyridinium increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC25A37 mRNA CTD PMID:28801915 Slc25a37 Mouse nitrofen increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 nitrofen results in increased expression of SLC25A37 mRNA CTD PMID:33484710 Slc25a37 Mouse oxaliplatin multiple interactions ISO Slc25a37 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Mouse oxaliplatin decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Mouse ozone multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA more ... CTD PMID:32699268 Slc25a37 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC25A37 mRNA CTD PMID:34911549 Slc25a37 Mouse paracetamol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC25A37 mRNA CTD PMID:21420995 Slc25a37 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA more ... CTD PMID:36331819 Slc25a37 Mouse phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SLC25A37 mRNA CTD PMID:19270015 Slc25a37 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SLC25A37 mRNA CTD PMID:23091169 Slc25a37 Mouse phosphane increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 phosphine results in increased expression of SLC25A37 mRNA CTD PMID:34427094 Slc25a37 Mouse pirinixic acid multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A37 mRNA CTD PMID:19710929 Slc25a37 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC25A37 mRNA CTD PMID:18301758 Slc25a37 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC25A37 mRNA CTD PMID:18445702 Slc25a37 Mouse potassium chromate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 Slc25a37 Mouse pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A37 mRNA CTD PMID:28903501 Slc25a37 Mouse propiconazole increases expression EXP 6480464 propiconazole results in increased expression of SLC25A37 mRNA CTD PMID:21278054 and PMID:22334560 Slc25a37 Mouse resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SLC25A37 mRNA CTD PMID:22610192 Slc25a37 Mouse rotenone increases expression ISO SLC25A37 (Homo sapiens) 6480464 Rotenone results in increased expression of SLC25A37 mRNA CTD PMID:29955902 Slc25a37 Mouse SB 431542 multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Mouse selenium atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 Slc25a37 Mouse serpentine asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of SLC25A37 mRNA CTD PMID:24160326 Slc25a37 Mouse silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SLC25A37 mRNA CTD PMID:19073995 Slc25a37 Mouse sodium arsenite decreases expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 and PMID:38568856 Slc25a37 Mouse sodium arsenite affects expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite affects the expression of SLC25A37 mRNA CTD PMID:29319823 Slc25a37 Mouse sunitinib increases expression ISO SLC25A37 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC25A37 mRNA CTD PMID:31533062 Slc25a37 Mouse tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Mouse tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Mouse testosterone multiple interactions ISO Slc25a37 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Mouse tetrachloromethane increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31150632 Slc25a37 Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31919559 Slc25a37 Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SLC25A37 mRNA CTD PMID:23557971 more ... Slc25a37 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of SLC25A37 gene CTD PMID:35295148 Slc25a37 Mouse topotecan decreases expression ISO Slc25a37 (Rattus norvegicus) 6480464 Topotecan results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Mouse topotecan multiple interactions ISO Slc25a37 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Mouse trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of SLC25A37 mRNA CTD PMID:19042947 Slc25a37 Mouse triphenyl phosphate affects expression ISO SLC25A37 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC25A37 mRNA CTD PMID:37042841 Slc25a37 Mouse tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of SLC25A37 mRNA CTD PMID:30912803 Slc25a37 Mouse valdecoxib increases expression ISO Slc25a37 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of SLC25A37 mRNA CTD PMID:24136188 Slc25a37 Mouse valproic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A37 mRNA CTD PMID:24935251 and PMID:29154799 Slc25a37 Mouse vincristine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Vincristine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Mouse zinc atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318 Slc25a37 Mouse zinc(0) increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318